By combining standard desensitization of up to five food allergies with antibody-based medication omalizumab, it may be possible to treat multiple food allergies in a shorter timeframe. This is according to a Phase 1 trial, with 25 patients, published in open access journal Allergy, Asthma & Clinical Immunology.

More...